Bioprocess Technology Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Assay Kits, Reagents, Beads, Micro Plates, Others), By Technique (Cell Culture, Cell Expansion, Cell Line Development, Cell Counting, Flow cytometry, Virus Filtration, Biological Safety Testing, Pyrogen Testing, Others), By Application (Biopharmaceuticals, Agriculture Industry, Petroleum Industry, Chemical Industry, Others), By End-User (Hospitals, Academic and Research Laboratories, Biopharmaceuticals and Biotechnology companies), and Region Forecast 2020-2031

Bioprocess Technology Market was valued at US$ 29,356.1 million in 2023 and is expected to grow at 12.7% CAGR from 2024 to 2030. The increase in the incidence of infectious and chronic diseases. The increased demand for decadent food from wine and beer to bread, cheese, and yogurt for their enhanced variables like texture, flavour, and shelf life is expected to drive the bioprocess technology market. Bioprocess technology is an industrial process that deals with the design and advancement of instrumentation and processes involving living cells or their components to effect the desired transformation of substrates to form more specific, efficient, and renewable by-products (biomass).

Moreover, the mass production of vaccines, painkillers, and cancer therapies after approval are all applications of bioprocessing in the pharmaceutical sector. For example, in 2022 CDER approved 37 new drugs thus increasing the demand for bioprocess technologies. Furthermore, the use of consolidated bioprocessing (CBP), separate hydrolysis and fermentation (SHF), simultaneous saccharification and fermentation (SSF), and new technological developments for generating macromolecules and aromatic compounds using renewable feedstocks for petroleum-based, textiles, pharmaceutical, and food-based industries have created several opportunities for the significant growth of the market.

However, due to the growing demand for recombinant proteins for therapeutic applications, rising demand for personalized treatment, stronger R&D pipeline strategic expansion of key players the market is increasing and is expected to further increase in the forecasted years. For instance, Merck developed a new platform called BioContinuum™ for next-generation bioprocessing by converging steps to achieve bioprocessing goals. Based on products, the bioreactors segment is dominating the market owing to its continuous operations, easy-to-adapt and clean. For instance, in March 2018, Sartorius AG introduced an amber 250 HT perfusion bioreactor system for cell culture process development that provides a computerized parallel bioreactor system specially designed for rapid cell culture perfusion process development to optimize the production of therapeutic antibodies. But, the stringent regulatory policies and higher cost of technology are hindering the growth of the market.

Key Developments

• In December 2022, Getinge launched Livit Flex – an intuitive system for bioprocess control that will enable pharmaceuticals and biotech products to reach the market faster.
• In June 2021, The U.S. Department of Agriculture’s (US$A) National Institute of Food and Agriculture (NIFA) invested $5.4 million in bioprocessing, bioengineering, biofuels, and biobased product research.